Antoine Griezmann Signs with Orlando City SC

antoine griezmann — US news

“I am very excited to begin this next chapter of my career with Orlando City,” Antoine Griezmann stated following the announcement of his transfer.

Griezmann, who is a 2018 FIFA World Cup winner, has signed with Orlando City SC from Atlético Madrid. His contract will commence in July 2026 and will run through the 2027-28 season, with an option for 2028-29.

At 35 years old, Griezmann has had a decorated career, becoming Atlético Madrid’s all-time leading scorer with 211 goals. He has also logged an impressive 298 goals and provided 132 assists across 792 professional appearances.

Mark Wilf, a representative from Orlando City SC, remarked, “Bringing Antoine to Orlando is a landmark moment not only for our club, but for our city, our supporters and for Major League Soccer.” This transfer is seen as a significant boost for the team as they aim to enhance their competitive edge in the league.

Ricardo Moreira, another club official, praised Griezmann’s abilities, saying, “Antoine is a complete footballer—creative, intelligent, clinical—and he is a proven winner on the biggest stages of the game.” This sentiment reflects the high expectations surrounding Griezmann’s arrival.

Griezmann’s recent performance with Atlético Madrid has been noteworthy, with 13 goals and four assists in the current season. His contributions have solidified his status as a key player in the league.

After announcing his retirement from international play in 2024, Griezmann has focused on his club career, where he scored 44 goals for the French national team, ranking fourth in the nation’s history.

“From my first conversations with the Club, I could feel a strong ambition and a clear vision for the future, and that really spoke to me,” Griezmann added, highlighting the alignment between his goals and those of Orlando City SC.

As Griezmann prepares for this new chapter, fans eagerly anticipate his impact on the team and the league as a whole.

Details remain unconfirmed.